Stock comparison
Aktis Oncology
AKTS$1.72BHealthcare Market cap, Sector
Jeena Sikho Lifecare Limited
JSLL.BO$74.9BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
AKTS 07 JSLL.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
AKTS0wins
7winsJSLL.BO
55D
B84
46D
A87
82B
A92
5F
C66
4F
B75
82B
A91
88A
A95
Side-by-side metrics
| Metric | AKTS | JSLL.BO |
|---|---|---|
| Market cap | $1.72B | $74.9B Winner |
| P/E (TTM) | Winner: - | 33.2x |
| EV/EBIT | Winner: - | 24.1x |
| ROIC (TTM) | -10.12% | 39.15% Winner |
| Gross margin | Winner: 89.19% | 88.58% |
| Net margin | -7.55% | 27.68% Winner |
| Revenue CAGR 5y | - | 57.81% |
| EPS CAGR 5y | - | 86.67% |
| Debt / Equity | Winner: 0.0x | 0.3x |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AKTS leads on
- P/E (TTM)-vs 33.2x+172%
- EV/EBIT-vs 24.1x+138%
- Debt / Equity0.0xvs 0.3x+92%
JSLL.BO leads on
- ROIC (TTM)39.15%vs -10.12%+126%
- Net margin27.68%vs -7.55%+104%
- Market cap$74.9Bvs $1.72B+98%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.